483
Center for Fertility and Reproductive Endocrinology UPPCenter for Fertility and Reproductive Endocrinology UPP – FDA 483, Dec 8, 2021
Record Details
An FDA inspection of Center for Fertility and Reproductive Endocrinology UPP in Pittsburgh, PA, revealed deficiencies in donor screening practices. The firm failed to adequately screen donors for communicable disease risk factors due to an incomplete donor risk assessment questionnaire. Additionally, an ineligible donor with risk factors for communicable disease agents was determined eligible and transferred to a recipient.
- Inspection date
- December 8, 2021
- Product type
- biologics
View Company Profile
ID · 6a3fe83d-f04f-4ff0-bb01-c224fd427dc7
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.